Ann-Kristin Porth

Dr. Ann-Kristin Porth

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Diabetic Medicine
Verified
Journal Article
Open access
APAnn-Kristin Porth
Ann-Kristin Porth
AHAnouk Sjoukje Huberts
Anouk Sjoukje Huberts
ARAlizé Rogge
Alizé Rogge
ABAngèle Helene Marie Bénard
Angèle Helene Marie Bénard
AFAngus Forbes
Angus Forbes
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer
Objective: Standardised person‐reported outcomes (PRO) data can contextualise clinical outcomes enabling precision diabetes monitoring and care. Comprehensive outcome sets can guide this process, but their implementation in routine diabetes care has remained challenging and unsuccessful at international level. We aimed to address this by developing a person‐centred outcome set for Type 1 and Type 2 diabetes, using a methodology with prospects for increased implementability and sustainability in international health settings.Methods: We used a three‐round questionnaire‐based Delphi study to reach consensus on the outcome set. We invited key stakeholders from 19 countries via purposive snowball sampling, namely people with diabetes (N = 94), healthcare professionals (N = 65), industry (N = 22) and health authorities (N = 3), to vote on the relevance and measurement frequency of 64 previously identified clinical and person‐reported outcomes. Subsequent consensus meetings concluded the study.Results: The list of preliminary outcomes was shortlisted via the consensus process to 46 outcomes (27 clinical outcomes and 19 PROs). Two main collection times were recommended: (1) linked to a medical visit (e.g. diabetes‐specific well‐being, symptoms and psychological health) and (2) annually (e.g. clinical data, general well‐being and diabetes self management‐related outcomes).Conclusions: PROs are often considered in a non‐standardised way in routine diabetes care. We propose a person‐centred outcome set for diabetes, specifically considering psychosocial and behavioural aspects, which was agreed by four international key stakeholder groups. It guides standardised collection of meaningful outcomes at scale, supporting individual and population level healthcare decision making. It will be implemented and tested in Europe as part of the H2O project.

1 January 2024 in BMJ Mental Health
Verified
Journal Article
Open access
PDF file
APAnn-Kristin Porth
Ann-Kristin Porth
YSYuki Seidler
Yuki Seidler
PLPreston Long
Preston Long
TSTanja Alexandra Stamm
Tanja Alexandra Stamm
AHAnouk S Huberts
Anouk S Huberts
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer
Background Diabetes increases the risk of psychosocial health problems. Person-centred psychosocial care is therefore advocated. However, several barriers to implementation exist, including uncertainty about how to approach psychosocial problems in consultations. Objective We aimed to explore which psychosocial outcomes patients and healthcare professionals consider important and whether certain characteristics are associated with this. We propose strategies for facilitating psychosocial diabetes care on this basis. Methods The results of an international Delphi study aimed at achieving multi-stakeholder consensus on a diabetes outcome set were analysed. We compared the importance ratings of the two stakeholder groups for each psychosocial outcome. A multivariable linear regression analysis tested whether certain characteristics would predict the importance attributed to outcomes that were not generally considered important. Findings Patients and healthcare professionals agreed on the importance of regularly assessing psychological well-being, diabetes distress and diabetes-specific quality of life, while they regarded it as less important to monitor depression, anxiety, eating problems, social support and sexual health. Being a woman, younger and living with type 1 diabetes were associated with considering it important to assess eating problems. Conclusions We propose two psychosocial care pathways that reflect the outcome preferences of patients and healthcare providers. They follow a stepped approach, starting with the assessment of psychological well-being and quality of life and proceeding from there. Clinical implications Adopting this approach can facilitate the implementation of person-centred psychosocial diabetes care by reducing the burden and making psychosocial issues more accessible. This approach should be tested for feasibility, safety and effectiveness.

25 July 2024 in Patient Education and Counseling
Verified
Journal Article
Open access
APAnn-Kristin Porth
Ann-Kristin Porth
YSYuki Seidler
Yuki Seidler
PLPreston Alexander Long
Preston Alexander Long
AHAnouk Sjoukje Huberts
Anouk Sjoukje Huberts
KHKathryn Hamilton
Kathryn Hamilton
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer
Objective: Despite improvements in diabetes monitoring and treatment many patients do not achieve treatment goals. Person-centred approaches have been proposed. However, their practical implementation lags. One barrier is uncertainty about which person-reported outcomes (PROs) should be considered to add the most value. We sought to identify PROs that may be prioritised. Methods: We used data from a multi-stakeholder Delphi study aimed at developing a person-centred diabetes outcome set and analysed which PROs patients considered important for regular monitoring but healthcare providers less so. Linear regression analyses tested whether belonging to either stakeholder group would predict the importance attributed to an outcome. Results: We found disagreement between patients and healthcare providers on eleven PROs. Stakeholder group predicted perceived importance for ten: self-management behaviours (including performance, perceived importance, motivation, and capacity), sleep quality, diabetes symptoms, screening visit attendance, health status, lifestyle behaviours, and side effects. Conclusion: Our findings suggest that, according to patients' preferences, self-management behaviours, health status and sleep are currently not adequately considered in diabetes management, compromising person-centred care. Practical implications: This study suggests that prioritising these PROs can facilitate the implementation of more person-centred diabetes monitoring which may support better-informed treatment decisions to achieve treatment goals.

8 November 2025 in European Journal of Internal Medicine
Verified
Journal Article
Open access
APAnn-Kristin Porth
Ann-Kristin Porth
APAnete Palma
Anete Palma
BSBurcu Sallarel
Burcu Sallarel
DPDimitrios Patoulias
Dimitrios Patoulias
DMDirk Müller-Wieland
Dirk Müller-Wieland
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer
People with diabetes and obesity have an increased risk of hospitalisation and in-hospital complications. Rising prevalence of diabetes and obesity, including their co-occurrence, "diabesity", make guideline-compliant treatment increasingly important. However, evidence on specific in-hospital diabesity treatment is limited. We aimed to characterise inpatients with diabetes/diabesity and evaluate their in-hospital care to identify challenges in inpatient diabetes/diabesity management. Cross-sectional data was collected from patient records and ward charts. We analysed differences between inpatients with and without diabesity and explored in-hospital diabetes treatment. We further compared inpatients with type 2 diabetes who started insulin treatment or received cardioprotective glucose-lowering agents to those who did not and used logistic regression to identify predictors of insulin initiation and use of cardioprotective agents. We included 207 people with diabetes from eight European hospitals, 50 % with diabesity. Most inpatients had a HbA1c >6.5 % (48 mmol/mol). Among inpatients with type 2 diabetes, one third did not have a recent HbA1c reading, blood glucose levels were monitored <3 times daily, and only 40 % of those with cardiovascular/renal disease received cardioprotective therapies. HbA1c, creatinine and at-home medications predicted insulin initiation, while admission cause and BMI predicted use of cardioprotective agents. We observed an underuse of cardioprotective glucose-lowering therapies, low rates of glycaemic monitoring, and low availability of HbA1c readings, concluding that clinical guidelines are not sufficiently implemented in everyday practice in Europe. Based on this, we advocate for better staff training, involvement of diabetologists, and raising awareness of the benefits of cardioprotective agents in the hospital.

12 December 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
AHAnouk S. Huberts
Anouk S. Huberts
PLPreston Long
Preston Long
APAnn-Kristin Porth
Ann-Kristin Porth
LFLiselotte Fierens
Liselotte Fierens
NCNicholas C. Carney
Nicholas C. Carney
TSTanja Alexandra Stamm
Tanja Alexandra Stamm
Background: A key barrier to realizing the full potential and long-term collection of patient-reported outcomes (PROs) is the limited understanding of user experience (UX) factors that influence sustained patient engagement with digital PRO tools. Most existing research focuses on disease-specific or country-specific solutions, leaving a gap in identifying shared UX determinants that could inform scalable, cross-disease European digital health frameworks. This fragmentation hinders interoperability and increases development costs by requiring separate tools for each context. This case study aims to address this gap by identifying key UX features that optimize PRO collection across diverse chronic conditions in Europe within the Health Outcomes Observatory project, enhancing continuous (primary use) and large-scale (secondary use) data collection. Objective: This study aimed to identify and analyze key UX factors that support adoption and sustained use of PRO collection tools among patients with chronic diseases across multiple European countries. Methods: Patient focus groups were conducted in four chronic disease areas: cancer, inflammatory bowel disease (IBD), and diabetes (type I and II) across six European countries. Participants were recruited purposively through national patient advisory boards to ensure diversity in age, gender, and disease type. Sessions were moderated by trained qualitative researchers following a standardized guide, and discussions were transcribed verbatim and coded in researcher pairs to ensure intercoder reliability through iterative consensus. A modified thematic analysis, guided deductively by the UX Honeycomb model and inductively by emergent themes, was used to identify cross-disease UX determinants. Results: In total, 17 patients and patient representatives participated (76% female; 4 diabetes, 6 IBD and 7 cancer). We identified six core UX factors driving patient engagement for all disease groups: compatibility with other technologies, direct communication with the care team, personalization, ability to share data, the need for educational material and data protection were identified as key aspects of PRO technologies. However, the customizability of the app is crucial. Not all disease groups had the same needs, and participants specifically requested that the app provide information relevant to their own condition. Disease-specific needs, like T1D patients desiring glucose monitoring integration, were identified. IBD patients highlighted flare detection abilities and cancer patients especially sought side-effect comparisons. Conclusions: Our findings indicate that a unified yet customizable PRO platform can address shared UX needs across diseases, improving patient engagement and data quality. Incorporating features such as seamless data transfer, personalization, feedback, and strong privacy measures can foster trust and long-term adoption across European contexts. In addition to some disease-specific issues, most needs for the backbone of the app were shared among the disease areas. This shows that a shared app between diseases might be preferable and, in case of comorbidities, could ease self-management for patients. Last, to ensure full potential for every user and every disease, customization is crucial.

6 March 2026 in JMIR Preprints
Verified
Preprint
Open access
PLPreston Long
Preston Long
GGGemma Galan
Gemma Galan
CWCarolina E. Watson
Carolina E. Watson
YCYolima Cossio-Gil
Yolima Cossio-Gil
MAMargaret Renn Andrews
Margaret Renn Andrews
TSTanja Alexandra Stamm
Tanja Alexandra Stamm
BACKGROUND The integration of patient-reported outcomes (PROs) into routine clinical practice remains limited despite their well-documented benefits in facilitating clinical communication and research. Systematic digital PRO collection can enable real-time symptom monitoring, timely clinical interventions, and greater patient empowerment. The Health Outcomes Observatory (H2O) initiative was developed to enable systematic digital patient-reported outcome measures (PROMs) collection and integration with clinical data to support value-based, patient-centered care across health care systems. OBJECTIVE This study aimed to evaluate the feasibility, usability, acceptability, clinical utility, and implementation of the H2O digital infrastructure from patient and health care professional perspectives across multiple health care settings and medical conditions. METHODS A noninterventional, multicenter, convergent mixed methods feasibility study was conducted in Spain, Austria, the Netherlands, and Germany across multiple medical conditions. Locally implemented smartphone, tablet, and web-based solutions captured and displayed PROs. Surveys and interviews assessed usability, acceptability, perceived clinical utility, and implementation conditions among patients and health care professionals. RESULTS Of 241 participants assessed initially, 115 (47.7%) contributed follow-up data. Although 83% (44/53) of the respondents indicated willingness to recommend H2O, the mean System Usability Scale (SUS) score was 44.65/100 (SD 9.78), indicating poor usability. Among 50 participants with paired Patient Satisfaction Questionnaire Short Form assessments, satisfaction with technical quality declined (t49=2.20; P=.03). Interviews identified perceived value alongside login difficulties, technical instability, weak integration with clinical systems, and inconsistent use of PRO data during consultations. CONCLUSIONS The H2O infrastructure could be deployed across heterogeneous settings, and participants perceived value in digital PRO collection; however, poor usability, substantial attrition, technical friction, and limited workflow integration qualify conclusions about feasibility and acceptability. More reliable technology, stronger interoperability, and evaluation in larger and more complete samples are needed before broader implementation. CLINICALTRIAL